Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal [clone 2-25LE] (IgG1) to Human Lewis B Blood Group Antigen
IHC - Paraffin, Western blot, ELISA
Human Lewis B Blood Group Antigen
Human (tested or 100% immunogen sequence identity)
IgG1 Monoclonal [2-25LE]
Protein A purified
IHC - Paraffin (10 µg/ml), Western blot, ELISA
Specificity and Use
Mucin isolated by size exclusion chromatography from an ovarian cyst fluid (pure endocervical type according to the Fenoglio's classification).
Reacts with Lewis b blood group antigen, a carbohydrate determinant carried on both glycolipids and glycoproteins, detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals
Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody,
PBS, 15 mM sodium azide, pH 7.4.
Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles.
Anti-Lewis B Blood Group Antigen antibody IHC of human small intestine. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B7885 dilution 10 ug/ml.
Requested From: United States
Date Requested: 8/27/2016